Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Sun Pharmaceutical Industries, Inc. with status No longer listed by FDA. The shortage was first posted on Jul 14, 2023. Reported reason: Other
Shortage details
- Status
- No longer listed by FDA
- Company
- Sun Pharmaceutical Industries, Inc.
- Package NDC
- 57664-047-88
- Dosage Form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-047-88)
- Initial Posting
- Jul 14, 2023
Reason
Other